Prudential Financial Inc Arcus Biosciences, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 55,905 shares of RCUS stock, worth $881,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,905

Previous 58,455 4.36%

Holding current value

$881,621

Previous $890,000 4.04%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.69 - $18.01 $34,909 - $45,925	-2,550 Reduced 4.36%	55,905 $854,000
Q2 2024 Aug 13, 2024	SELL	$14.59 - $18.48 $70,761 - $89,628	-4,850 Reduced 7.66%	58,455 $890,000
Q1 2024 May 14, 2024	BUY	$14.83 - $20.18 $15,571 - $21,189	1,050 Added 1.69%	63,305 $1.2 Million
Q4 2023 Feb 13, 2024	SELL	$13.43 - $19.63 $186,945 - $273,249	-13,920 Reduced 18.27%	62,255 $1.19 Million
Q3 2023 Nov 13, 2023	SELL	$17.62 - $23.54 $36,649 - $48,963	-2,080 Reduced 2.66%	76,175 $1.37 Million
Q2 2023 Aug 11, 2023	BUY	$16.97 - $22.03 $242,212 - $314,434	14,273 Added 22.31%	78,255 $1.59 Million
Q1 2023 May 12, 2023	SELL	$15.96 - $23.15 $29,765 - $43,174	-1,865 Reduced 2.83%	63,982 $1.17 Million
Q4 2022 Feb 14, 2023	SELL	$19.7 - $35.71 $4,826 - $8,748	-245 Reduced 0.37%	65,847 $0
Q3 2022 Nov 04, 2022	BUY	$23.23 - $30.07 $106,974 - $138,472	4,605 Added 7.49%	66,092 $1.73 Million
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $657,152 - $1.44 Million	38,140 Added 163.36%	61,487 $1.56 Million
Q1 2022 May 13, 2022	SELL	$28.92 - $41.83 $8,907 - $12,883	-308 Reduced 1.3%	23,347 $737,000
Q4 2021 Feb 14, 2022	SELL	$31.38 - $48.47 $5,491 - $8,482	-175 Reduced 0.73%	23,655 $957,000
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $10,233 - $14,318	380 Added 1.62%	23,830 $831,000
Q2 2021 Aug 16, 2021	SELL	$22.75 - $35.77 $479,592 - $754,067	-21,081 Reduced 47.34%	23,450 $644,000
Q1 2021 May 12, 2021	BUY	$26.16 - $41.39 $8,946 - $14,155	342 Added 0.77%	44,531 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$17.0 - $32.36 $288,660 - $549,472	-16,980 Reduced 27.76%	44,189 $1.15 Million
Q3 2020 Nov 16, 2020	SELL	$17.14 - $25.47 $327,802 - $487,113	-19,125 Reduced 23.82%	61,169 $1.05 Million
Q2 2020 Aug 12, 2020	BUY	$13.97 - $36.56 $781,118 - $2.04 Million	55,914 Added 229.34%	80,294 $1.99 Million
Q1 2020 May 12, 2020	SELL	$8.78 - $19.28 $380,437 - $835,402	-43,330 Reduced 63.99%	24,380 $338,000
Q4 2019 Feb 11, 2020	BUY	$7.33 - $10.79 $496,314 - $730,590	67,710 New	67,710 $683,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.6M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.14B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Arcus Biosciences, Inc. Transaction History